Intas Pharmaceuticals Ltd.
Healthcare
Company watch: PE-backed Intas Pharma enjoying a healthy dose of growth
It was in 1996 that Intas Pharmaceuticals Ltd first attracted a private equity investor. Twenty-one years later, PE firms’ interest ......
Healthcare
Capital International acquires 3% stake in Intas
Capital International Inc has acquired a 3% stake in Ahmedabad-based Intas Pharmaceuticals Ltd, news reports said.Both Mint and The Times ......
Healthcare
Aurobindo, Intas bid for Teva's products in Europe
Indian drugmakers Aurobindo Pharma and Intas Pharmaceuticals have submitted binding bids to acquire products from Israel’s Teva Pharmaceutical Industries in the ......
Pharmaceuticals
RPG Life Sciences sells biotech business to Intas Pharma
Mumbai-based RPG Life Sciences Ltd, an integrated pharmaceutical firm operating in the domestic and international ......
Healthcare
Intas Pharma buys a unit of Spain's Combino Pharm
Ahmedabad-based Intas Pharmaceuticals Ltd has acquired a part of Spanish firm Combino Pharm for an undisclosed amount, to strengthen its ......
Healthcare
Rewind 2014: PE dealmaking in healthcare skids; M&As brighten
Healthcare sector saw private investments shrink in 2014 after hitting an all-time high the previous year. Lack of big ticket ......
Pharmaceuticals
Temasek receives CCI nod to buy 10.16% stake in Intas Pharma from ChrysCap
Singapore’s sovereign fund Temasek has got the approval from Competition Commission of India (CCI) to buy part of the ......
Healthcare
Temasek emerges as the frontrunner to buy stake in Intas Pharma from ChrysCap
Singapore’s sovereign fund Temasek Holdings has emerged as the front runner in the race to acquire a little over 10 ......
Healthcare
Intas Pharma may reconsider proposed IPO, could look at PE deal to give ChrysCap part exit
Intas Pharmaceuticals Ltd, which had filed its draft red-herring prospectus (DRHP) with SEBI for a proposed initial public offering (IPO) ......
Healthcare
Intas Pharma files DRHP with SEBI; ChrysCapital eyes 13-14x part-exit
Ahmedabad-based Intas Pharmaceuticals Ltd has filed draft red-herring prospectus (DRHP) with the market regulator for an issue which will see ......